CES attendees saw health-tracking gadgets making bold promises: toothbrushes detecting diabetes, mirrors assessing 20-year ...

TÜV Rheinland has introduced a closed-loop recycled material verification process to help the electronics industry manage growing e-waste volumes and comply with increasingly strict regulatory demands ...

The algorithm allows users to manage their type 1 diabetes without needing to count carbohydrates or providing pre-meal ...

Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study in collaboration with CardioFocus.

Makers of smartwatches and other wearables have spent years trying to measure blood sugar without pricking your skin. The ...

The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.

Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.

AP31969 is a novel, first-in-class, oral SK ion channel inhibitor intended for rhythm control of atrial fibrillation and has recently completed Phase 1 in healthy volunteersPhase 2 trial will assess ...

On the eve of CES 2026 in Las Vegas, we look back at the best products we saw last January to see which ones delivered on ...

After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had to be paused for about a month due to safety concerns, as four neurovascular ...

On Monday, the U.S. Food and Drug Administration (FDA) approved Abbott Laboratories’ (NYSE: ABT) Volt PFA System to treat patients battling atrial fibrillation (AFib). AFib is the most common type of ...

CHICAGO (WLS) -- An alleged serial puncher has been ordered detained on Friday after officials say he attacked at least six women in separate incidents downtown. The state's attorney's office says ...